Showing results (641-650 of 667) with videos related to
Sort By:
Pageof 67
Medical Oncology (Northwood, London, England)|September 29, 2011
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTsJ F Emile, S Brahimi, J M Coindre, et al.Oncogene|February 19, 2021
Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasisHyunho Yoon, Chih-Min Tang, Sudeep Banerjee, et al.Blood|January 9, 2010
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AMLJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT InhibitionRichard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.Blood|August 6, 2005
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemiaRoss L Levine, Marc Loriaux, Brian J P Huntly, et al.Leukemia|April 9, 2025
Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final resultsAndreas Hochhaus, Dong-Wook Kim, Jorge E Cortes, et al.Leukemia|May 16, 2024
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up resultsJorge E Cortes, Koji Sasaki, Dong-Wook Kim, et al.The New England Journal of Medicine|August 16, 2002
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumorsGeorge D Demetri, Margaret von Mehren, Charles D Blanke, et al.Journal of Translational Medicine|December 16, 2016
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumorsEileen Shi, Juliann Chmielecki, Chih-Min Tang, et al.Cancer Cell|July 18, 2006
Activating alleles of JAK3 in acute megakaryoblastic leukemiaDenise K Walters, Thomas Mercher, Ting-Lei Gu, et al.Pageof 67